title: Analysis of common PTPN1 gene variants in type 2 diabetes, obesity and associated phenotypes in the French population.
abstract: BACKGROUND
  The protein tyrosine phosphatase-1B, a negative regulator for insulin and leptin signalling, potentially modulates glucose and energy homeostasis. PTP1B is encoded by the PTPN1 gene located on chromosome 20q13 showing linkage with type 2 diabetes (T2D) in several populations. PTPN1 gene variants have been inconsistently associated with T2D, and the aim of our study was to investigate the effect of PTPN1 genetic variations on the risk of T2D, obesity and on the variability of metabolic phenotypes in the French population.
  
  
  METHODS
  Fourteen single nucleotide polymorphisms (SNPs) spanning the PTPN1 locus were selected from previous association reports and from HapMap linkage disequilibrium data. SNPs were evaluated for association with T2D in two case-control groups with 1227 cases and 1047 controls. Association with moderate and severe obesity was also tested in a case-control study design. Association with metabolic traits was evaluated in 736 normoglycaemic, non-obese subjects from a general population. Five SNPs showing a trend towards association with T2D, obesity or metabolic parameters were investigated for familial association.
  
  
  RESULTS
  From 14 SNPs investigated, only SNP rs914458, located 10 kb downstream of the PTPN1 gene significantly associated with T2D (p = 0.02 under a dominant model; OR = 1.43 [1.06-1.94]) in the combined sample set. SNP rs914458 also showed association with moderate obesity (allelic p = 0.04; OR = 1.2 [1.01-1.43]). When testing for association with metabolic traits, two strongly correlated SNPs, rs941798 and rs2426159, present multiple consistent associations. SNP rs2426159 exhibited evidence of association under a dominant model with glucose homeostasis related traits (p = 0.04 for fasting insulin and HOMA-B) and with lipid markers (0.02 = p = 0.04). Moreover, risk allele homozygotes for this SNP had an increased systolic blood pressure (p = 0.03). No preferential transmission of alleles was observed for the SNPs tested in the family sample.
  
  
  CONCLUSIONS
  In our study, PTPN1 variants showed moderate association with T2D and obesity. However, consistent associations with metabolic variables reflecting insulin resistance and dyslipidemia are found for two intronic SNPs as previously reported. Thus, our data indicate that PTPN1 variants may modulate the lipid profile, thereby influencing susceptibility to metabolic disease.
authors: CNRS UMR 8090, Institut de Biologie de Lille, Institut Pasteur, 59019 Lille, France. claire.cheyssac@good.ibl.fr
authors: Claire
authors: C
authors: Cheyssac
authors: Cécile
authors: C
authors: Lecoeur
authors: Aurélie
authors: A
authors: Dechaume
authors: Amina
authors: A
authors: Bibi
authors: Guillaume
authors: G
authors: Charpentier
authors: Beverley
authors: B
authors: Balkau
authors: Michel
authors: M
authors: Marre
authors: Philippe
authors: P
authors: Froguel
authors: Fernando
authors: F
authors: Gibson
authors: Martine
authors: M
authors: Vaxillaire